PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsTetraphase Pharmaceuticals
Tetraphase Pharmaceuticals(TTPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XeravaEravacycline2018-08-272029-2037
Infections
,
Bacterial infections
,
Intraabdominal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Eravacycline
chronic kidney failure
,
kidney diseases
,
healthy volunteers/patients
,
hematologic neoplasms
,
neutropenia
,
neoplasms
,
intraabdominal infections
,
urinary tract infections
,
appendicitis
,
bacterial infections
,
infections
,
bacterial pneumonia
,
sepsis
,
multiple drug resistance
,
pneumonia
,
acinetobacter baumannii
,
pulmonary infarction
,
pharmacokinetics
,
bacterial drug resistance
Benzocaine
acne vulgaris
Corticorelin
retinal diseases
,
kidney diseases
,
chronic renal insufficiency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic kidney failure
,
anemia
,
renal insufficiency
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
Edetic acid
carcinoma
,
anus neoplasms
,
squamous cell carcinoma
Lactams
breast neoplasms
Curcumin
chronic kidney failure
,
bullous pemphigoid
,
hemolytic anemia autoimmune
,
breast neoplasms
,
lobular carcinoma
,
ductal carcinoma breast
Trinessa
healthy volunteers/patients
Fluoroquinolone
community-acquired infections
,
urinary tract infections
,
pyelonephritis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use